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Objectives: to study the technical feasibility and results of endovascular treatment of inflammatory abdominal aortic
aneurysms (AAA).
Design: prospective study.
Material and methods: seven patients underwent endovascular repair of an inflammatory AAA. Five patients (8 ureters)
were treated with ureteric stents CT scans were obtained one year.
Results: the early technical success rate was 100%. Four ureters remained entrapped at one year. Partial regression of
periaortic fibrosis was documented in three patients, while four patients showed no regression.
Conclusion: endovascular reconstruction of inflammatory abdominal aneurysms is technically feasible. Further study is
warranted with regard to the evolution of the periaortic fibrosis and the possible benefits for patients with concomitant
hydronephrosis.
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Inflammatory abdominal aortic aneurysms (IAAA)
are a variant of atherosclerotic AAA and have an
incidence ranging from 2.2 up to 18.1%.1 They are
characterised by dense periaortic fibrosis that may
entrap various anatomical structures. In 15±30% of
the cases one or both ureters are involved leading to
hydronephrosis and even uraemia.2
Due to the periaortic fibrosis, the surgical treatment
of an IAAA is considered more difficult resulting in a
higher morbidity and mortality rate, especially when
ureterolysis is performed in case of associated hydro-
nephrosis.2±6
This may render endovascular repair an attractive
alternative.7 In this report we describe our experience
in seven patients, of whom five presented with asso-
ciated hydronephrosis.
Patient, Material and Methods
Between January 1996 and June 1999, we observed 37
patients with an IAAA. All on the basis of contrastPlease address all correspondence to: A. Nevelsteen, Department
of Vascular Surgery, University Clinic Gasthuisberg, Heerenstraat 49,
3000 Leuven, Belgium.
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endovascular repair was thought possible in seven
cases (Figs 1a, 2a) (all male, mean age of 59 [range
51±70] years). Four patients had smoked for over
30 years, and three had symptomatic coronary artery
disease two were being treated for arterial hyper-
tension. None of the patients was diabetic or suffered
from cerebrovascular insufficiency.
Three patients were asymptomatic. One presented
with atypical abdominal pain, while another three
were admitted with acute renal failure due to bilateral
hydronephrosis. Two of these three were initially
treated at the department of Urology with a bilateral
nephrostomy, followed after three days by bilateral
ureteric stent insertion. The third patient received
immediately a bilateral ureteral stent. All three patients
regained normal renal function after one week.
CT-scan also documented associated unilateral
hydronephrosis in two of the three asymptomatic
patients. One of these patients received a unilateral
ureteral stent. The hydronephrosis in the last patient,
also due to periaortic fibrosis, was left alone, because
it concerned a very small non-functional kidney.
After discharge, all patients were followed accord-
ing to the Eurostar protocol.9 Decrease or increase of
periaortic fibrosis at 1 year was defined as a change of
the fibrosis thickness of at least 25% in comparison
with the preoperative measurements.1l rights reserved.
Fig. 1. Preoperative (a) and 1-year postoperative (b) CT scan demonstrating partial but not complete regression of periaortic fibrosis.
Fig. 2 Preoperative (a) and 1-year postoperative (b) CT scan: no regression of periaortic fibrosis and continuing ureteric entrapment.
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All procedures were done in the operation theatre
under general anaesthesia. Five different endoprosth-
eses were used according to the availability of the
stent grafts, the preoperative measurements and the
preference of the surgeon: Stentor (Mintec, La Ciotat,
France) n 1, Talent (Medtronic World Medical,
Sunrise, FL, U.S.A.) n 1, Excluder (Gore WL and
associates, Flagstaff, AZ, U.S.A.) n 1, Vanguard(Boston Scientific Corporation, Natick, MA, U.S.A.)
n 2 and Zenith (Cook Inc., Bloomington, U.S.A.)
n 2. All stent grafts could be placed accurately
(immediate technical success rate 100%). One patient
sustained peroperatively a rupture of the common
iliac artery with massive blood loss during post-
deployment molding of the (Talent) endograft.
He was treated by temporary balloon tamponade
and extension of the stent graft to the external
iliac artery.Eur J Vasc Endovasc Surg Vol 24, August 2002
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and the mean hospital stay was five days (range
4±13 days). The mean follow-up period of this series
was 29 months (range 18±60 months). There were no
late deaths, but two patients developed a graft related
complication. The first patient, who received a Zenith
graft presented with claudication due to graft limb
stenosis after 15 months. He was handled by percu-
taneous dilatation and stenting. The second patient
developed a graft limb thrombosis after 26 months
(Vanguard endograft) and was successfully treated
with a femorofemoral crossover graft.
With regard to the associated hydronephrosis
(five patients), four of the seven ureteral stents (two
patients) were removed within 6 months. These two
patients were followed further on by spiral CT-scan
for respectively 53 and 12 months and developed no
signs of ureteral entrapment. In the two other cases of
treated hydronephrosis, the three ureteral stents were
repetitively removed resulting each time in restenosis.
Despite concomitant and aggressive corticosteroid
treatment, these stents are still in place after respec-
tively 28 and 27 months. As already stated, hydrone-
phrosis was not treated in the fifth patient, and here
also there was no regression.
Detailed data on preoperative and 1 year aneurysm
diameter and evolution of periaortic fibrosis are
shown in Table 1. The median preoperative maximum
aneurysm diameter was 48 mm (range 42±68 mm). The
median thickness of the periaortic fibrosis was 14 mm
(range 9±22 mm). The median maximum aneurysm
diameter at 1 year was 45 mm (range 40±54 mm).
None of the patients showed complete regression
of the periaortic fibrosis. Partial regression
(425% decrease) was noted in three cases (Fig. 1b),
while four patients showed no regression at all
(Fig. 2b). These four also include the two patients
with continuing ureteric obstruction. Finally, none ofTable 1. Preoperative and 1 year postoperative CT data.
Patient 1 2 3# 4 5 6 7 Median
Aneurysm diameter mm
preoperative 48 48 50 60 68 45 42 48 mm
postoperative 40 47 48 40 54 45 41 45 mm
Periaortic fibrosis mm
preoperative 20 12 18 16 14 09 09 14 mm
postoperative PR PR PR NC NC NC NC
Ureter obstruction
preoperatively P P P P P A A
1 year postoperatively A A P P P A A
Bilateral ureter obstruction
# Patient with one afunctional kidney.
PR: Partial regression  25% decrease of fibrosis; NC: No change; A:
Absent; P: Present.
Eur J Vasc Endovasc Surg Vol 24, August 2002the patients showed worsening of the peri-aortic fibro-
sis on the one year postoperative CT scan.
Discussion
The surgical treatment of IAAA is frequently asso-
ciated with an elevated mortality and morbidity
rate.2,10±14
Simple ureteric stenting without ureterolysis might
reduce the incidence of pre- and postoperative
complications.2,11,12
Endovascular repair of IAAA has been mentioned
only anecdotally in the literature.7,15,16 Our report con-
firms that it can be safely performed from a technical
point of view. More recently, Vallabhaneni et al.
reported on a series of six patients.8 Based on CT
scan performed 6 months postoperatively, they docu-
mented worsening of the periaortic fibrosis resulting
in ureteric obstruction in two patients. In the remain-
ing four patients, the fibrosis did not reduce post-
operatively. In our series, we did not observe
worsening of the periaortic fibrosis. However none of
our patients showed complete regression, while
partial regression was noted in three cases only.
Although none of our patients developed ureteric
obstruction after endovascular repair, preoperative
ureteric entrapment was cured in only two patients,
while two other patients continue to have ureteric
obstruction after more than 2 years. When compared
with open surgery, this suggests at least a less favour-
able evolution.2,17
Also because there is no uniform theory to explain
the development of IAAA, we can only speculate on
the reasons for these observations. In open surgery, it
has been documented that `` old'' peri-aortic fibrosis
with a cell/fibrosis rate 51 tends to decrease far
less easily in the postoperative period than `` young''
fibrosis with a cell/fibrosis rate 41.1 Although, due to
the endovascular approach, we have no pathologic
proof, it might therefore be that the patients without
regression of the fibrosis in our series all presented
with `` old'' fibrosis. Some authors have suggested that
IAAA might result from aneurysm expansion result-
ing in lymphatic stasis and peri-aortic fibrosis.6,18,19
In our series, the patients with ureteric involvement
presented indeed with the largest aneurysms. It is also
striking that the two patients without relief of ureteric
involvement presented with the largest aneurysms
preoperatively. These results support the last men-
tioned theory.
In conclusion, we certainly admit that our find-
ings should be interpreted with caution since our
experience consists of only seven patients. At least,
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technically feasible and safe in case of IAAA. Our
experience warrants however also further study with
regard to the possible benefits of endografting in
patients with concomitant hydronephosis.
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